Key Highlights

• FMC shares rose 7.39% pre-market to $12.35 after the investment announcement.

• Tessenderlo Group will invest approximately $400 million at $13.30 per share.

• The transaction gives Tessenderlo an approximate 20% ownership stake in FMC.

• Proceeds are expected to help FMC reach its roughly $1 billion debt paydown target.

Investment Concludes Strategic Review

FMC Corporation (NYSE:FMC) shares gained in pre-market trading after the agricultural sciences company reached a definitive agreement for a strategic minority equity investment from Tessenderlo Group, a Belgium-based industrial group listed in Brussels. Under the agreement, Tessenderlo will invest approximately $400 million at a price of $13.30 per share, resulting in an ownership stake of roughly 20% of FMC's outstanding common stock.

The transaction concludes a review of strategic options that FMC's board initiated in February 2026. Company statements indicated the proceeds will be directed toward debt reduction, helping the company reach its approximately $1 billion debt paydown target.

Additional Steps Toward Financial Flexibility

The Tessenderlo investment follows a series of separate actions FMC has taken in recent months to strengthen its balance sheet, including an amendment to its revolving credit facility for covenant relief, a $1.2 billion secured high-yield bond offering, the planned sale of its India commercial business for $252 million, a supply and license agreement with Corteva that included a $200 million prepayment, and a framework agreement for a $114 million sale and leaseback of its Newark, Delaware property.

Company leadership said the combined actions position FMC to advance its research pipeline and commercialize new products as an independent company. The transaction remains subject to customary closing conditions, including regulatory approvals.

Conclusion

The Tessenderlo investment provides FMC with a substantial capital infusion aimed at addressing leverage concerns that have weighed on the stock over the past year. Combined with the company's other recent financing and asset sale actions, the deal gives FMC a clearer path toward its debt reduction targets while it continues developing new agricultural science products.

 

This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own research before making financial decisions.